MAYHEM capsules — Class II drug recall D-0314-2015
Terminated recall by Chaotic Labz, reported 2014-12-31, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and
| Recall number | D-0314-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Chaotic Labz, Atkins, AR, United States |
| Recall initiated | 2014-11-14 |
| Classified | 2014-12-22 |
| Reported by FDA | 2014-12-31 |
| Terminated | 2017-01-13 |
| Distributed | Nationwide (US) |
| Quantity | 990 bottles |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00628586678057 |
| Lot numbers | 06/16, CLM061114 |
Product
MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7.
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0314-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.